---
title: "BUZZ-MIRA Pharmaceuticals jumps as oral pain drug beats morphine in animal study"
description: "MIRA Pharmaceuticals' shares surged 90% to $2.52 in premarket trading after its oral drug, Mira-55, outperformed morphine in an animal study for chronic inflammatory pain. The drug effectively normali"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261424289.md"
published_at: "2025-10-16T11:08:49.000Z"
---

# BUZZ-MIRA Pharmaceuticals jumps as oral pain drug beats morphine in animal study

> MIRA Pharmaceuticals' shares surged 90% to $2.52 in premarket trading after its oral drug, Mira-55, outperformed morphine in an animal study for chronic inflammatory pain. The drug effectively normalized pain levels and reduced inflammation by targeting CB2 receptors, while morphine only partially alleviated inflammation. This positive data supports MIRA's plans for a marketing application for Mira-55. Year-to-date, shares have increased approximately 16%.

Shares of drug developer MIRA Pharmaceuticals (MIRA.O) rise 90% to $2.52 premarket

Company says its experimental oral drug, Mira-55, eased pain and reduced swelling better than injected morphine in a pre-clinical animal study for chronic inflammatory pain

Mira-55 brought pain levels back to normal and directly reduced inflammation by targeting the CB2 receptor - MIRA

CB2 receptors are expressed in immune cells and are involved in the regulation of immune responses and inflammation

Company says morphine only partially reduced inflammation

Data supports marketing application plans for Mira-55 for chronic inflammatory pain - MIRA

Up to last close, shares up ~16% YTD

### Related Stocks

- [MIRA.US - Mira Pharmaceuticals](https://longbridge.com/en/quote/MIRA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Mira Pharmaceuticals' Oral Mira-55 Outperforms Morphine in Pain Relief and Inflammation Reduction, Preclinical Study Shows | Mira Pharmaceuticals Inc. announced preclinical results showing that its oral marijuana analog, Mira-55, outperformed mo | [Link](https://longbridge.com/en/news/261314660.md) |
| China’s Bio-Thera Gets EU’s Marketing Approval for Its Inflammatory Autoimmune Disease Drug | China’s Bio-Thera Solutions has received EU marketing approval for its drug Gotenfia (golimumab injection), aimed at tre | [Link](https://longbridge.com/en/news/275867563.md) |
| Even Elephants Have Enemies: 8 Animals That Can Take Them Down | The article discusses the surprising fact that elephants, despite being the largest land animals, can have predators. It | [Link](https://longbridge.com/en/news/276250634.md) |
| Tractor Supply Announces a Flock of Animal-Friendly Festivities Launching This Month \| TSCO Stock News | Tractor Supply Company (NASDAQ: TSCO) is launching a series of animal-focused events in February, including Chick Days a | [Link](https://longbridge.com/en/news/276063929.md) |
| 16:47 ETPet Partners Nominations Open for 2026 Pet of the Year, Celebrating the Moments Pets Change Lives | Pet Partners has opened nominations for the 2026 Pet of the Year fundraiser, inviting pet lovers to recognize pets that  | [Link](https://longbridge.com/en/news/276173667.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.